Despite Tonghua's fair revenue rise, its high P/S ratio migh...
Despite Tonghua's fair revenue rise, its high P/S ratio might imply overvaluation. Investors appear to expect substantial business improvement, ignoring its modest recent growth. Current shareholders could face disappointment if the P/S ratio aligns more with growth rates. Significant performance improvement is crucial to prevent a share price decline.
Revenues Not Telling The Story For Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SZSE:000766) After Shares Rise 40%
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment